Rigel Pharmaceuticals, Inc.

Q4 2024 13F Holders

Symbol
RIGL
CUSIP
766559702
Type
Equity
Class
COM
Num filings
122
Total reported value, excl. options
$203 M
Manager Report Date Value ($000) Shares Option Type